J&J deal requires at least 95% claimant participation
Johnson & Johnson (J&J) has agreed to settle ovarian talc claims for $5.5 billion, with the settlement contingent on at least 95% claimant participation, as reported in latest updates on 2026-07-27 (sources: multiple news alerts dated 2026-07-27).